Furazidin, vaginal tablets, 5mg, Dalacin 20 mg/g hüvelykrém
FUR-05-24
Phase 3 small_molecule active
Quick answer
Furazidin, vaginal tablets, 5mg, Dalacin 20 mg/g hüvelykrém for Bacterial vaginosis is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Bacterial vaginosis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active